Regeneron Pharmaceuticals Inc.'s dispute with Merus NV involving a patent on antibody-producing mice has caused an uproar over an appeals court's expansion of inequitable conduct to include behavior by an attorney during litigation.
The inequitable conduct doctrine holds that a patent is unenforceable if the patent applicant is found to have withheld material...





